도네페질(Donepezil) 시장 보고서(2025년)

Donepezil is a medication used to manage symptoms of Alzheimer's disease by preventing the breakdown of acetylcholine, a neurotransmitter essential for memory and cognition. As a cholinesterase inhibitor, it enhances cognitive function and helps slow symptom progression in patients with mild to moderate Alzheimer's disease.

The primary dosage forms of donepezil include 5 mg, 10 mg, and 23 mg. The 5 mg dosage specifically refers to donepezil hydrochloride, commonly prescribed for treating dementia associated with Alzheimer's disease. It is administered through various routes, such as oral and transdermal, and is utilized across multiple settings, including hospitals, clinics, and drugstores.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The donepezil market research report is one of a series of new reports from The Business Research Company that includes donepezil market statistics, including donepezil industry global market size, regional shares, competitors with a donepezil market share, detailed donepezil market segments, market trends and opportunities, and any further data you may need to thrive in the donepezil industry. This donepezil market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The donepezil market size has grown steadily in recent years. It will grow from $1 billion in 2024 to $1.04 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to the increasing prevalence of Alzheimer's disease, the growing geriatric population, the rise in government spending and programs, the rising awareness of neurodegenerative disorders, and the rise in demand for high-quality nucleic acid samples.

The donepezil market size is expected to see steady growth in the next few years. It will grow to $1.24 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to rising healthcare expenditure, increasing focus on early diagnosis of Alzheimer's, growing demand for combination therapies, growing investment in healthcare infrastructure, and growing consciousness about neurodegenerative illnesses. Major trends in the forecast period include innovations in drug formulations and delivery methods, technological advancements, the launch of novel dosage forms and formulations, the approval of generic versions of donepezil, and advanced research facilities.

The forecast of 4.5% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. memory clinics by driving up costs of donepezil hydrochloride tablets sourced from China and South Korea, exacerbating Alzheimer's disease treatment expenses and increasing cognitive disorder management burdens. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of Alzheimer's disease is expected to drive the growth of the donepezil market. Alzheimer's disease is a progressive neurological disorder that leads to brain cell degeneration and death, resulting in memory loss, cognitive decline, and behavioral changes. The rise in Alzheimer's cases is attributed to factors such as an aging population, population growth, lifestyle-related risks, the increase in chronic diseases, genetic predisposition, and environmental exposures. Donepezil plays a crucial role in managing Alzheimer's symptoms by improving cognitive function and daily living abilities through its effect on acetylcholine levels in the brain. For instance, in May 2024, a report by the Alzheimer's Association, a US-based nonprofit dedicated to Alzheimer's care, support, and research, indicated that the number of Americans aged 65 and older diagnosed with Alzheimer's dementia increased from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the rising incidence of Alzheimer's disease is fueling the expansion of the donepezil market.

Leading companies in the donepezil market are focusing on developing innovative technologies such as advanced transdermal systems to enhance patient compliance and treatment effectiveness through extended-release formulations. The donepezil system refers to the pharmacological mechanism of action of donepezil, a medication primarily used for treating Alzheimer's disease and other forms of dementia. For instance, in October 2022, Corium Innovation Inc., a US-based biopharmaceutical company, launched the donepezil transdermal system (Adlarity) for treating patients with mild, moderate, or severe Alzheimer's disease dementia. This transdermal formulation delivers donepezil directly through the skin, bypassing the digestive system, thereby reducing gastrointestinal side effects and offering a more convenient administration method. This innovation benefits both Alzheimer's patients and their caregivers by improving adherence to treatment.

In August 2023, Corium Innovation Inc. partnered with Lotus Pharmaceuticals to expand the availability of ADLARITY(R) in multiple Asian markets. The partnership includes a license agreement for ADLARITY, an innovative donepezil transdermal system for treating Alzheimer's dementia, across ten markets in Asia. Lotus Pharmaceuticals, a Taiwan-based pharmaceutical company, specializes in commercializing both novel and generic pharmaceuticals, helping to bring advanced Alzheimer's treatments to a broader global population.

Major players in the donepezil market are AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Inc., Intas Pharmaceuticals Ltd., Mylan NV, Sandoz Group AG, Hetero Drugs Ltd., Sun Pharmaceutical Inc., Eisai Co. Ltd., Cipla Ltd., Dr Reddy's Laboratories, Apotex Inc., H Lundbeck A/S, Zydus Cadila, Amneal Pharmaceuticals LLC, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Jubilant Pharmova Ltd., Wockhardt Ltd., Luoxin Pharmaceuticals Group.

North America was the largest region in the donepezil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in donepezil report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the donepezil market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The donepezil market consists of sales of orally disintegrating tablets, experimental and niche products, active pharmaceutical ingredients, and combination medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Donepezil Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on donepezil market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for donepezil ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The donepezil market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: 5mg; 10mg; 23mg
• 2) By Route Of Administration: Oral; Transdermal
• 3) By Application: Hospitals; Clinics; Drugstore
• Subsegments:
• 1) By 5mg: Immediate-Release 5mg; Orally Disintegrating 5mg
• 2) By 10mg: Immediate-Release 10mg; Orally Disintegrating 10mg
• 3) By 23mg: Extended-Release 23mg; Film-Coated 23mg
• Companies Mentioned: AbbVie Inc.; Pfizer Inc.; Teva Pharmaceutical Inc.; Intas Pharmaceuticals Ltd.; Mylan NV; Sandoz Group AG; Hetero Drugs Ltd.; Sun Pharmaceutical Inc.; Eisai Co. Ltd.; Cipla Ltd.; Dr Reddy's Laboratories; Apotex Inc.; H Lundbeck A/S; Zydus Cadila; Amneal Pharmaceuticals LLC; Torrent Pharmaceuticals Ltd; Alkem Laboratories Ltd.; Jubilant Pharmova Ltd.; Wockhardt Ltd.; Luoxin Pharmaceuticals Group
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Donepezil Market Characteristics

3. Donepezil Market Trends And Strategies

4. Donepezil Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Donepezil Growth Analysis And Strategic Analysis Framework

• 5.1. Global Donepezil PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Donepezil Market Growth Rate Analysis
• 5.4. Global Donepezil Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Donepezil Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Donepezil Total Addressable Market (TAM)

6. Donepezil Market Segmentation

• 6.1. Global Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 5mg
• 10mg
• 23mg
• 6.2. Global Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Transdermal
• 6.3. Global Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Drugstore
• 6.4. Global Donepezil Market, Sub-Segmentation Of 5mg, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate-Release 5mg
• Orally Disintegrating 5mg
• 6.5. Global Donepezil Market, Sub-Segmentation Of 10mg, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate-Release 10mg
• Orally Disintegrating 10mg
• 6.6. Global Donepezil Market, Sub-Segmentation Of 23mg, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Extended-Release 23mg
• Film-Coated 23mg

7. Donepezil Market Regional And Country Analysis

• 7.1. Global Donepezil Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Donepezil Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Donepezil Market

• 8.1. Asia-Pacific Donepezil Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Donepezil Market

• 9.1. China Donepezil Market Overview
• 9.2. China Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Donepezil Market

• 10.1. India Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Donepezil Market

• 11.1. Japan Donepezil Market Overview
• 11.2. Japan Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Donepezil Market

• 12.1. Australia Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Donepezil Market

• 13.1. Indonesia Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Donepezil Market

• 14.1. South Korea Donepezil Market Overview
• 14.2. South Korea Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Donepezil Market

• 15.1. Western Europe Donepezil Market Overview
• 15.2. Western Europe Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Donepezil Market

• 16.1. UK Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Donepezil Market

• 17.1. Germany Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Donepezil Market

• 18.1. France Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Donepezil Market

• 19.1. Italy Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Donepezil Market

• 20.1. Spain Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Donepezil Market

• 21.1. Eastern Europe Donepezil Market Overview
• 21.2. Eastern Europe Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Donepezil Market

• 22.1. Russia Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Donepezil Market

• 23.1. North America Donepezil Market Overview
• 23.2. North America Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Donepezil Market

• 24.1. USA Donepezil Market Overview
• 24.2. USA Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Donepezil Market

• 25.1. Canada Donepezil Market Overview
• 25.2. Canada Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Donepezil Market

• 26.1. South America Donepezil Market Overview
• 26.2. South America Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Donepezil Market

• 27.1. Brazil Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Donepezil Market

• 28.1. Middle East Donepezil Market Overview
• 28.2. Middle East Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Donepezil Market

• 29.1. Africa Donepezil Market Overview
• 29.2. Africa Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Donepezil Market Competitive Landscape And Company Profiles

• 30.1. Donepezil Market Competitive Landscape
• 30.2. Donepezil Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Teva Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Intas Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Mylan NV Overview, Products and Services, Strategy and Financial Analysis

31. Donepezil Market Other Major And Innovative Companies

• 31.1. Sandoz Group AG
• 31.2. Hetero Drugs Ltd.
• 31.3. Sun Pharmaceutical Inc.
• 31.4. Eisai Co. Ltd.
• 31.5. Cipla Ltd.
• 31.6. Dr Reddy's Laboratories
• 31.7. Apotex Inc.
• 31.8. H Lundbeck A/S
• 31.9. Zydus Cadila
• 31.10. Amneal Pharmaceuticals LLC
• 31.11. Torrent Pharmaceuticals Ltd
• 31.12. Alkem Laboratories Ltd.
• 31.13. Jubilant Pharmova Ltd.
• 31.14. Wockhardt Ltd.
• 31.15. Luoxin Pharmaceuticals Group

32. Global Donepezil Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Donepezil Market

34. Recent Developments In The Donepezil Market

35. Donepezil Market High Potential Countries, Segments and Strategies

• 35.1 Donepezil Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Donepezil Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Donepezil Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer